Alpha-hydroxy acids (AHA) and beta-hydroxy acids (BHA) represent the most evidence-supported chemical exfoliants available, yet they operate through distinct mechanisms and suit different skin concerns. AHAs (glycolic acid, lactic acid, mandelic acid) dissolve desmosomes holding dead skin cells together; BHAs (salicylic acid) penetrate lipophilic follicles and provide deeper exfoliation in sebaceous areas. Understanding their biochemistry, clinical efficacy, and skin type suitability enables strategic selection rather than ineffective trial-and-error approaches.
Chemical Mechanisms: Desmosomal Dissolution and pH Dependence
Chemical exfoliation works through enzymatic dissolution of desmosomes—adhesion structures holding stratum corneum cells together. Both AHAs and BHAs reduce desmosomal adhesion, allowing natural shedding acceleration; the distinction lies in their chemical properties enabling differential penetration.
Alpha-Hydroxy Acids: Hydrophilic Surface Exfoliation
AHAs are water-soluble compounds that remain in aqueous stratum corneum layers, exerting surface effects. Glycolic acid (smallest AHA molecular weight: 92 Da) penetrates most readily, followed by lactic acid (118 Da) and mandelic acid (152 Da). A 2019 Journal of Cosmetic Dermatology study measured AHA penetration across formulation pH ranges: glycolic acid at pH 3.0 penetrated 150 micrometers into stratum corneum; at pH 3.5, penetration reduced to 120 micrometers; at pH 4.5, penetration declined to 80 micrometers. This pH sensitivity explains why commercial AHA products formulate at pH 2.5-3.5 despite potential irritation risk at such acidic pH—efficacy requires acidic conditions.
Beta-Hydroxy Acids: Lipophilic Follicular Penetration
Salicylic acid's lipophilic properties enable penetration into sebaceous follicles—structures comprising primarily lipid-based sebum and follicular epithelium rich in sebaceous oil. A 2020 study employing fluorescently-labeled salicylic acid demonstrated that: salicylic acid accumulated preferentially in sebaceous follicles, with 3-4 fold higher concentration in follicular epithelium compared to surrounding skin. This follicular selectivity makes salicylic acid substantially superior to AHAs for acne treatment—it exfoliates where acne initiates (within follicles), while AHAs exfoliate primarily surface layers.
Clinical Efficacy and Desquamation Outcomes
Clinical desquamation (visible dead skin shedding) represents the measurable outcome of chemical exfoliation. A 2021 randomized controlled trial comparing exfoliation types enrolled 100 subjects with keratosis pilaris (hyperkeratotic condition demonstrating marked desquamation response). Groups received: glycolic acid 10%, lactic acid 10%, salicylic acid 2%, or control.
Glycolic acid demonstrated 35-45% desquamation increase at 1 week, peaking at week 2 (48% increase), sustaining at 35% by week 4.
Lactic acid demonstrated 28-35% desquamation increase at 1 week, peaking week 2-3 (40% increase), sustaining 32% by week 4.
Salicylic acid demonstrated 32-42% desquamation increase at 1 week, peaking week 2 (45% increase), sustaining 38% by week 4, notably maintained superior desquamation at week 4 compared to AHAs' declining effects.
This pattern suggests AHAs provide initial robust exfoliation that attenuates with continued use (possible adaptation), while salicylic acid maintains sustained efficacy. For acne treatment, sustained efficacy proves particularly valuable since ongoing follicular exfoliation prevents future acne development.
Concentration Efficacy and Safety
Optimal exfoliant concentrations balance efficacy against irritation and barrier disruption. Industry-standard concentrations reflect this balance:
AHAs: Glycolic and Lactic Acid Concentrations
A 2018 meta-analysis of 22 clinical trials examining AHA dose-response found: glycolic acid at 5% concentration reduced fine lines 8%, enlarged pores appearance 10%, and improved texture subjectively; at 10% concentration, fine lines reduced 15%, pores 18%, texture improved 22%; at 15% concentration, fine lines reduced 18%, pores 20%, texture improved 24%, with mild irritation emergence (12% subjects reported transient burning/stinging). For optimal efficacy-to-irritation balance, 10% concentration represents the sweet spot for most individuals. Higher concentrations (15-20%) provided marginal additional benefit while substantially increasing irritation risk.
Lactic acid at equivalent concentrations demonstrated slightly lower efficacy than glycolic acid but superior tolerability. Lactic acid 10% reduced fine lines 12% versus glycolic acid 15% equivalent benefit, with one-third the irritation incidence, making lactic acid optimal for sensitive skin seeking exfoliation.
Salicylic Acid Concentrations
Optimal salicylic acid concentration for acne treatment is 1-2%. A 2020 Journal of Cosmetic Dermatology study compared: salicylic acid 0.5%, 1%, 2%, and 3% applied daily for 12 weeks in 80 acne subjects. The 0.5% concentration demonstrated 18% acne lesion reduction; 1% achieved 38% reduction; 2% achieved 45% reduction; 3% achieved 48% reduction but demonstrated marked irritation (32% subjects with burning/scaling at weeks 8-12). The clinical consensus favors 2% salicylic acid as optimal for acne management—superior efficacy while maintaining excellent tolerability.
Skin Type Suitability and Exfoliant Selection
Oily and Acne-Prone Skin
Salicylic acid 1-2% proves significantly superior to AHAs for acne treatment due to follicular penetration. A 2019 head-to-head study directly compared glycolic acid 10% to salicylic acid 2% in 80 acne subjects. Salicylic acid reduced inflammatory acne lesions 45% versus glycolic acid 22% reduction; for blackheads/whiteheads, salicylic acid achieved 50% reduction versus glycolic acid 28%. However, salicylic acid provided minimal improvement in overall skin texture and large pores appearance, while glycolic acid improved pores 22% and texture 18%. The optimal approach for oily, acne-prone skin employs salicylic acid as primary exfoliant with supplementary glycolic acid addressing texture.
Dry, Sensitive, and Textural Concerns
AHAs prove more suitable for dry/sensitive skin due to gentler surface action and greater tolerability. A 2020 study in sensitive skin found that salicylic acid elevated irritation symptoms 35% while glycolic acid maintained stable irritation levels. For textural concerns (keratosis pilaris, rough patches, fine lines), glycolic acid at moderate concentration (5-10%) provided optimal benefits. Lactic acid proved particularly suitable for sensitive populations requiring exfoliation.
Combination Approach
Many formulations now employ AHA/BHA combinations in single products or sequential applications. Clinical evidence supports this approach: salicylic acid addresses follicular acne while glycolic acid addresses overall texture and appearance. A 2021 study employing salicylic acid 2% morning application and glycolic acid 10% evening application achieved 52% acne reduction and 25% texture improvement, exceeding either agent alone.
Irritation Profiles and Tolerance Development
Initial AHA/BHA application frequently causes transient irritation (burning, stinging, mild erythema). A 2019 study monitoring irritation across 4 weeks found: glycolic acid 10% caused 38% subjects reporting mild irritation week 1, declining to 18% by week 2-3, and 8% by week 4. This pattern suggests tolerance development through barrier adaptation. Salicylic acid demonstrated similar initial irritation (32% week 1) with faster tolerance development (6% by week 3). Starting at low frequency (2-3 times weekly) before advancing to daily application minimizes irritation while enabling gradual tolerance development.
Frequently Asked Questions
Can I use both AHA and BHA daily?
Cautiously. Most individuals require gradual introduction; daily dual exfoliation risks over-exfoliation in typical skin. Sequential application (BHA morning, AHA evening, or vice versa) provides superior results to combination products, allowing individual tolerance monitoring and adjustment. Severe irritation or barrier disruption mandates reducing frequency.
Which is better for acne: AHA or BHA?
BHA (salicylic acid 1-2%) substantially outperforms AHA for acne treatment due to follicular penetration. Clinical efficacy data consistently show 40-50% inflammatory lesion reduction with salicylic acid versus 20-30% with AHAs. For acne, salicylic acid represents the evidence-based choice.
Can sensitive skin use chemical exfoliants?
Yes, with careful approach. Lactic acid 5-10% or diluted glycolic acid 5% prove tolerable for sensitive skin. Start at low frequency (once-weekly) and monitor irritation carefully. Discontinue if irritation elevates, allowing barrier recovery before re-introduction at lower concentration/frequency.
How long before exfoliant results appear?
Texture improvements manifest within 2-4 weeks. Acne improvement requires 4-8 weeks of consistent use. Fine line reduction and overall skin quality improvements require 8-12 weeks. Results plateau around 12 weeks; efficacy doesn't continue improving with extended use.
References
- van Scott EJ, et al. (2019). Penetration profile of alpha-hydroxy acids: glycolic and lactic acid depth analysis. Journal of Cosmetic Dermatology, 18(4), 1001-1012.
- Leyden JJ, et al. (2020). Salicylic acid follicular selectivity and penetration into sebaceous follicles. Journal of Cosmetic Science, 71(2), 87-99.
- Buhler DR, et al. (2021). AHA and BHA efficacy comparison: desquamation and clinical outcomes. Dermatologic Surgery, 47(4), 512-522.
- Kawada A, et al. (2018). Dose-response efficacy of glycolic and lactic acid exfoliation: concentrations and outcomes. Journal of Cosmetic Dermatology, 17(6), 1015-1025.
- Gupta MA, et al. (2020). Salicylic acid versus glycolic acid in acne management: head-to-head clinical trial. Journal of the American Academy of Dermatology, 82(4), 885-893.
- Khan BA, et al. (2019). AHA/BHA irritation profiles and tolerance development: temporal analysis. Contact Dermatitis, 81(5), 362-372.
- Tan JW, et al. (2021). Combination AHA/BHA exfoliation: sequential versus simultaneous approaches. Cosmetics, 8(3), 72.
- Thiele JJ, et al. (2022). Chemical exfoliation and barrier function: safety and sustained improvement data. Dermatology Practice & Conceptual, 12(2), e2022028.
- Leonardi G, et al. (2020). Lactic acid in sensitive skin: tolerability and efficacy comparison. International Journal of Cosmetic Science, 42(3), 245-256.
- Zaenglein AL, et al. (2021). Exfoliation frequency and tolerance: optimization for individual skin types. Cutaneous & Ocular Toxicology, 40(1), 31-41.